GlobeNewswire Inc | Sep 22, 2020 12:37PM EDT

September 22, 2020

PHILADELPHIA, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NextCure, Inc. (NextCure or the Company) (NASDAQ: NXTC) to determine whether the Company engaged in securities fraud or other unlawful business practices.

NextCureinvestors who purchased, or otherwise acquired, the Companys common stock between November 5, 2019 and July 14, 2020, inclusive (the Class Period), AND/OR pursuant or traceable to the Companys Registration and Prospectus filed with the SEC on November 12 and 18, 2019, and suffered losses greater than $100,000 are encouraged to complete Kehoe Law Firms Securities Class Action Questionnaire or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804,myarnoff@kehoelawfirm.com, securities@kehoelawfirm.com, to discuss thesecurities investigation or potential legal claims.

A class action lawsuit filed against NextCure in United States District Court alleges that the NextCure Defendants misled investors by issuing false and misleading statements concerningthe effectiveness of NC318, the responses observed in patients treated with NC318, and NC318s potential to treat patients refractory to PD-1 therapies. According to the class action complaint, the Defendants statements were materially misleading, because the NC318 data Defendants possessed showed a lack of efficacy and objective responses. Had the truth been revealed, according to the complaint, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiffside law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.